Insights, Education, Research & News on Prostate Cancer

August 17, 2026

What "Clinically Significant" Prostate Cancer Actually Means

"Clinically significant" appears in MRI reports and biopsy results without anyone explaining it. It describes prostate cancer likely to grow, spread, or cause harm, as opposed to cancer that may never do either. That judgment rests mostly on grade. The two numbers in a Gleason score tell you which growth patterns are present and which one dominates, which is why 3+4 and 4+3 total the same yet mean different things. Grade Group 2 and above is generally treated as significant, though the line is debated and depends on the patient.

Prostate 101

August 12, 2026

How to Get a Copy of Your Own Prostate MRI

If you have had a prostate MRI, you have a legal right to receive a copy of it. That right covers more than the written report. The actual image files, stored in a format called DICOM, are part of your health record too, and they are what another radiologist or a second-opinion service needs in order to look at your scan again. This article explains the difference between the report and the images, who to contact at the imaging center, what to say when you ask, how long the process should take in the U.S., EU, and UK, what you can reasonably be charged, what to do if you are refused or delayed, and which free software will open the files once they arrive.

Prostate 101

August 4, 2026

What Information Can an MRI Provide That a PSA Test Cannot?

A PSA test gives one number for the whole prostate, and it can rise for reasons that have nothing to do with cancer. An MRI looks at the gland itself: where a suspicious area sits, how large it is, and how the tissue behaves. Neither test confirms cancer on its own. Understanding what each one contributes can make your next conversation with your physician a clearer one.

Prostate 101

July 5, 2026

Why Lesion Location Matters

When a prostate MRI report describes a lesion, most patients focus on whether it looks suspicious. But *where* the lesion sits inside the prostate is one of the first things radiologists evaluate, and it can shape how a finding is interpreted, how a biopsy might be planned, and what questions are worth raising with your care team. The prostate is divided into several regions, each with its own anatomy and its own challenges on MRI. This article explains those regions in plain language, why location influences an MRI suspicion score, and where a second, AI-supported review of a scan can fit into the picture. Location is only one piece of a larger clinical assessment, and no single detail on an MRI diagnoses or rules out cancer on its own.

Prostate 101

June 26, 2026

Can a Digital Rectal Exam Miss Prostate Cancer?

A normal digital rectal exam (DRE) can be reassuring, but it cannot rule out prostate cancer on its own. The reason is mostly anatomical: a physician can feel only the part of the prostate that sits against the rectal wall, so tumors toward the front or deeper inside the gland may produce no change a finger can detect. Over the past decade, the DRE's role has narrowed across the U.S., UK, and Europe, and it is now generally used alongside the PSA blood test and MRI rather than as a stand-alone screen. Because no single test settles the question, physicians weigh several factors together, and imaging, including a second AI-supported review, can add useful perspective before decisions about biopsy or monitoring are made.

Prostate 101

June 12, 2026

What Type of AI Is Reviewing Your Prostate MRI?

When people hear "artificial intelligence," they often think of chatbots, robots, or computers that think like humans. But the AI used in prostate MRI analysis is something very different. It belongs to a category called Narrow AI. In this article, we'll explore the three major types of AI based on ability and explain where prostate MRI analysis fits.

AI & Imaging

August 22, 2026

New UCL Research: Could a Prostate MRI Replace a Biopsy?

Four experienced radiologists at UCL and UCLH re-read 251 suspicious prostate MRIs and recorded how sure they felt about each one. When they said "99% sure," they were right. Every man in that group who went on to biopsy had clinically significant cancer. That level of certainty applied to only about 1 in 10 men coming through the clinic, and the authors call their findings hypothesis-generating. It still raises a question worth asking your doctor: how much is your MRI already telling you?

AI & Imaging

July 23, 2026

Why More Patients Are Getting an MRI Before Their First Biopsy

Prostate MRI is increasingly used before an initial biopsy because it can show suspicious areas, estimate prostate volume, and help physicians plan more targeted tissue sampling. In some patients with a reassuring MRI and a low-risk overall picture, it may also support a discussion about monitoring rather than biopsying immediately. MRI does not diagnose prostate cancer, and a negative result does not reduce the risk to zero. Decisions still depend on PSA information, personal risk factors, scan quality, physician judgment, and patient preferences. Guidance also differs between the United States, Europe, and the UK, which is one reason two men with similar results can receive different advice.

AI & Imaging

June 23, 2026

Prostate Cancer Is on the Rise. A Faster MRI Could Help More Men Get Answers.

Prostate cancer is now the most commonly diagnosed cancer in the United States and is rising about 3% a year. MRI has reshaped how it is evaluated, helping target biopsies and, for some men, avoid one. A shorter, contrast-free version of the scan called biparametric MRI (bpMRI) performed about as well as the longer multiparametric scan (mpMRI) in a large 2025 trial, while taking roughly half the time and costing far less. AI tools are also being studied to help radiologists read these scans more consistently. Together these advances could help more men get timely, accurate answers, though every scan and result still belongs in a conversation with a physician.

AI & Imaging

June 18, 2026

What Does Your Prostate Size Actually Tell Your Doctor?

Prostate size can play an important role in how doctors interpret PSA levels, evaluate urinary symptoms, calculate PSA density, and plan biopsies. This article explains why prostate volume matters, how MRI and AI-supported segmentation can provide more precise measurements, and why a more accurate understanding of prostate size can help patients and physicians make more informed decisions.

Prostate 101

June 12, 2026

What Type of AI Is Reviewing Your Prostate MRI?

AI & Imaging

March 19, 2026

Understanding Your PI-RADS Score

PI-RADS is the standardized scoring system used to interpret prostate MRI—but what do those scores really mean for your cancer risk and next steps? This guide breaks down the 1–5 scale, explains the difference between mpMRI and bpMRI, and clarifies common misconceptions—especially around the “gray zone” of PI-RADS 3. Understanding your score can reduce anxiety, improve decision-making, and help you have more informed conversations with your care team.

News & Updates

March 30, 2026

Precision Prostate Consulting Rebranded as DeepView Imaging

Precision Prostate Consulting, LLC (PPC), a leader in AI-powered prostate MRI analysis, today announced its official rebrand to DeepView Imaging. The new name reflects the company’s direct-access platform and its expanding mission to democratize access to fast, AI-powered second opinions for prostate MRI, delivering actionable imaging insights when patients need them most.

3 min read

News & Updates

February 23, 2026

Jamie Richgels Joins PPC as Managing Partner

Precision Prostate Consulting, LLC (PPC), a provider of AI-powered prostate cancer detection and diagnostic services, today announced the appointment of Jamie Richgels as Managing Partner. In this role, Richgels will lead the company’s strategic and technological growth initiatives while advancing PPC’s mission to expand access to high-quality prostate cancer diagnostics.“We are thrilled to welcome Jamie to the PPC leadership team,” said Dr. Randall W. Jones, PhD., Managing Partner of Precision Prostate Consulting.“

2 min read

Should I get an AI review of my MRI?

"Should I get an AI review of my MRI?"

Dr. Eric Walser, a pioneer in image-guided focal therapy for prostate cancer and BPH and former Professor and Chairman of Radiology at the University of Texas, raised a practical point on this recently.

When a doctor orders a prostate MRI, most patients simply go wherever the referral sends them. Whether that radiology practice uses AI in its reading workflow is largely invisible to the patient. In his words, "for a patient, it's really hit or miss."

His advice is to take control of your own imaging:

Get a copy. Those images belong to you. Ask for them on a disc, or through the download link many imaging centers now provide.

Keep them. If your PSA continues to rise years from now, comparing a new scan against an older one matters. Cancer tends to grow and change over time, while normal prostate tissue generally doesn't. It's the same principle behind comparing this year's mammogram to last year's.

Know your options. If you want a second look, you can send that imaging to a service that will analyze it with AI and return it to you with visual overlays highlighting areas of interest.

One caveat he's clear about: an AI analysis is information, not a decision. Understanding what it means for you, including whether a biopsy or treatment makes sense, still requires a conversation with a physician.

Should I Get a Second Opinion?

Should you get a second opinion on your prostate MRI?

In this short video, Dr. Eric Walser explains why a second MRI review may be worth considering and how AI can complement an expert's interpretation.

With decades of experience diagnosing and treating prostate disease, Dr. Walser is a recognized pioneer in MRI-guided prostate cancer treatment and the former Chairman of Radiology at the University of Texas

What Happens After an Elevated PSA?

An elevated PSA is not a cancer diagnosis. It is a question mark.

Dr. Eric Walser, a leading authority in image-guided prostate diagnosis and treatment, explains what may happen next and why prostate MRI is increasingly an important early step. Many conditions besides cancer can raise PSA, including an enlarged prostate and inflammation.

Three things worth knowing:

🔹MRI is usually the first step before biopsy: It can help identify possible benign explanations for an elevated PSA and reveal suspicious areas that may need closer evaluation.

🔹AI is helping: Prostate MRI is one of the fastest-growing scans in the country, and it's new enough that many radiologists were never trained specifically on it. AI helps pinpoint the areas that need expert eyes.

🔹Not every finding requires immediate treatment: Some prostate cancers grow very slowly, and low-grade disease is often monitored through active surveillance. The decision depends on your age, overall health, biopsy results, and the specifics of what was found.

As Dr. Walser explains, this can be a long journey with several important decision points. Having a physician who understands modern prostate cancer care, and asking plenty of questions, can help you make informed decisions together.

What Should Every Man Do Before Age 50?

Prostate health shouldn’t become a concern only when you reach your 50s or 60s.

Dr. Eric Walser makes the case for starting long before there is an elevated PSA, an MRI, or a prostate cancer diagnosis.

Healthy habits such as staying active, maintaining a healthy weight, not smoking, managing blood pressure, and eating a balanced diet are important for overall health. Research also suggests that some of these habits may be associated with a lower risk of aggressive or fatal prostate cancer.

Of course, lifestyle is only part of the picture. Age, family history, genetics, and ancestry can also affect prostate cancer risk.

Watch the short clip and share your thoughts: Did prostate health become something you thought about only later in life, or was it already on your radar?

I'm Worried About Prostate Cancer, What Should I do?

Worried about prostate cancer? A few steadying words from Dr. Eric Walser.

An elevated PSA or a recommended prostate MRI can be unsettling. In this video, Dr. Eric Walser, a recognized authority in minimally invasive, image-guided treatment for prostate cancer and former Professor & Chairman of Radiology at the University of Texas, shared two ideas worth holding onto.

First, don't be afraid of the MRI. Some men avoid it because of claustrophobia, but scans have gotten shorter and mild sedation is often available. What matters is the information the scan provides, which can help patients and their doctors avoid unnecessary biopsies and treatment.

Second, seek more than one opinion. After a biopsy or a diagnosis, different specialists may recommend different paths, and that can feel overwhelming. Dr. Walser points out that many men accept the first recommendation and undergo aggressive treatment they may not have needed. Talking with several doctors, often alongside a partner, can lead to a decision you feel comfortable with.

A prostate MRI holds a great deal of information, and a careful second look at that same scan can sometimes add useful perspective. DeepView Imaging offers an FDA-cleared AI-supported second analysis of a prostate MRI you already have, giving you and your care team another perspective to discuss, typically within 30 minutes. A second opinion can help confirm the initial interpretation or highlight additional areas of interest. It does not replace your radiologist or treating physician.

The decisions are yours to make, guided by the doctors who know your case.

‍